Human medicines European public assessment report (EPAR): Xalkori, crizotinib, Carcinoma, Non-Small-Cell Lung, Date of authorisation: 23/10/2012, Revision: 33, Status: Authorised

Human medicines European public assessment report (EPAR): Xalkori, crizotinib, Carcinoma, Non-Small-Cell Lung, Date of authorisation: 23/10/2012, Revision: 33, Status: Authorised

Human medicines European public assessment report (EPAR): Xalkori, crizotinib, Carcinoma, Non-Small-Cell Lung, Date of authorisation: 23/10/2012, Revision: 33, Status: Authorised

Human medicines European public assessment report (EPAR): Xalkori, crizotinib, Carcinoma, Non-Small-Cell Lung, Date of authorisation: 23/10/2012, Revision: 33, Status: Authorised

Human medicines European public assessment report (EPAR): Xalkori, crizotinib, Carcinoma, Non-Small-Cell Lung, Date of authorisation: 23/10/2012, Revision: 33, Status: Authorised

Wil je het laatste nieuws in jouw mailbox ontvangen?
Meld je dan aan voor de nieuwsbrief.